Discover how the Yokogawa CQ1 is revolutionizing high-content imaging in drug discovery. In this video, James Evans, CEO and Founder of PhenoVista Biosciences, explains how PhenoVista helps biotech and pharma clients answer critical questions about disease phenotypes and therapeutic interventions.
By leveraging state-of-the-art systems like the Yokogawa CQ1, PhenoVista enables researchers to access rich subpopulation and spatial data for precise analysis of test articles, from small molecules to antibodies, assessing potency and toxicity. James discusses how high-content imaging—powered by the CQ1 and PhenoVista’s collaborative approach—delivers unmatched insights into cell biology with exceptional resolution and throughput.
Whether ranking test compounds or evaluating complex disease models, the Yokogawa CQ1 accelerates discovery, enhances data accuracy, and supports the development of life-saving therapies. Learn how the CQ1’s cutting-edge features are driving more informed decision-making in drug discovery across critical therapeutic areas, including neurobiology, cardiology, and 3D oncology.
View CQ1 Product information here.
Related Industries
-
Life Sciences
The life science industry encompasses a broad range of sectors that are involved in the study, research, development, and commercialization of living organisms and biological systems. It is a highly diverse and dynamic field that includes pharmaceuticals, biotechnology, medical devices, diagnostics, bioinformatics, agricultural biotechnology, and more.